Parton J W, Probst G S, Garriott M L
Toxicology Division, Division of Eli Lilly and Company, Greenfield, IN 46140.
Mutat Res. 1988 Oct;206(2):281-3. doi: 10.1016/0165-1218(88)90172-3.
The ability of 2,6-xylidine to produce chromosome breakage and/or spindle malformation in vivo was evaluated by an assessment of the capacity of the compound to induce micronuclei in bone marrow polychromatic erythrocytes. Male ICR mice were administered a single oral dose of 350, 175 or 87.5 mg/kg of 2,6-xylidine by oral gavage and bone marrow was extracted from the femurs 24, 48 and 72 h thereafter. The frequency of micronuclei in animals treated with 2,6-xylidine was not different from that observed for the corresponding solvent treated controls.
通过评估2,6-二甲基苯胺在体内诱导骨髓多染红细胞微核的能力,来评价其产生染色体断裂和/或纺锤体畸形的能力。给雄性ICR小鼠经口灌胃单次给予350、175或87.5mg/kg的2,6-二甲基苯胺,然后在24、48和72小时后从股骨中提取骨髓。用2,6-二甲基苯胺处理的动物的微核频率与相应溶剂处理的对照组观察到的频率没有差异。